The Mint Julep Will Have to Wait | GenomeWeb

When the time came for Stephen Hoffman to retire, rocking chairs and golf clubs weren’t in the picture. The 52-year-old former leader of malaria research efforts and vaccine development for the US Navy served for 21 years, long enough to retire with full benefits, according to Navy policy. Rather than find a condo in Florida, Hoffman joined Celera in the new position of senior vice president of immunotherapies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.